Of great interest, increasing evidence has indicated that the Nrf2/antioxidant response might be impaired across a wide range of tissue types in diabetes [37], although the mechanisms underlying Nfr2 dysfunction also remain to be elucidated. The gene discussed is NFE2L2; the disease is diabetes mellitus.